Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome–positive B‐precursor acute lymphoblastic leukemiaAlessandro Rambaldi, Giovanni Martinelli, Hagop M. Kantarjian et al.|Cancer|2019Cited by 76